Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Innlanz Ltd

INL:ASX

Innlanz Ltd

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (AUD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-62.96%
  • Beta0.5097
Data delayed at least 20 minutes, as of May 24 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Innlanz Limited is an Australia-based retailer of cosmetics, jewelry, health, well-being, and wool products, serving the inbound Chinese tourism market in Australia and New Zealand. The Company, through its subsidiary, Ixora Investment Pty Ltd, owns the Heartland Ambassador Hamilton Hotel in New Zealand. Its other subsidiaries include Mediland Pharm NZ Ltd and The Collection Hotels and Resorts Pty Ltd.

  • Revenue in AUD (TTM)2.60m
  • Net income in AUD-572.07k
  • Incorporated2018
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Innlanz Ltd2.60m-572.07k3.13m----1.27--1.21-0.0018-0.00180.00830.00790.32913.4431.98---7.25-19.94-10.11-27.6297.4884.14-22.03-21.260.3286-2.150.4858--65.72-40.0468.03---46.77--
Elixinol Wellness Ltd8.48m-7.51m4.62m----0.4344--0.5452-0.013-0.0130.01410.00810.67331.792.99---59.59-77.11-89.54-84.5942.8349.78-88.51-308.550.9044-55.430.1619--19.85-25.7428.98---67.79--
Eve Health Group Ltd2.28m-1.99m5.27m----2.42--2.32-0.0004-0.00070.00040.00040.44622.2122.20---38.97-33.15-47.82-36.2830.6333.67-87.35-146.042.23-5,132.580.1348--16.00161.9454.10------
Oliver's Real Food Ltd25.22m-655.99k6.17m------5.500.2446-0.0016-0.00160.0607-0.03531.8915.56230.92---4.93-43.36-15.88-68.1263.9564.53-2.60-35.440.17480.27082.32--27.82-7.07150.48---49.45--
Data as of May 24 2024. Currency figures normalised to Innlanz Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.